Glutathione S-transferase P-p38 mitogen-activated protein kinase complex (GSTP1-p38 MAPK)

The Glutathione S-transferase P-p38 mitogen-activated protein kinase (GSTP1-p38 MAPK) complex is a regulatory protein-protein interaction that serves as a critical checkpoint in cellular stress signaling (Wu et al., 2006, Journal of Biological Chemistry). Under basal conditions, GSTP1 binds directly to p38 MAPK, sequestering it and preventing its phosphorylation by upstream mitogen-activated protein kinase kinases (MKKs), thereby inhibiting pro-apoptotic signaling (Townsend et al., 2003, Oncogene). Upon exposure to oxidative stress or specific small-molecule inhibitors, the complex dissociates, allowing p38 MAPK to become activated and trigger downstream pathways leading to cell cycle arrest or apoptosis (Laborde, 2010, Expert Opinion on Therapeutic Targets). This complex is of significant therapeutic interest because GSTP1 is frequently overexpressed in various human cancers, where it suppresses p38-mediated cell death and contributes to multi-drug resistance (Tew et al., 2011, Cancer Research). Pharmacological disruption of the GSTP1-p38 MAPK interaction using glutathione analogs like Ezatiostat or specialized inhibitors like NBD-hex represents a strategy to sensitize tumor cells to chemotherapy and overcome resistance mechanisms (Ruscoe et al., 2001, Journal of Pharmacology and Experimental Therapeutics). Beyond oncology, the regulation of this complex is implicated in inflammatory and neurodegenerative processes where redox-sensitive signaling is dysregulated.

Other names

GSTP1-p38 complexGSTP1-MAPK14 complexGlutathione S-transferase pi-p38 MAPK complexGSTP1-p38 interactionGSTP1-1-p38 MAPK complex

Small molecule-mediated disruption of the protein-protein interface, leading to the dissociation of GSTP1 from p38 MAPK and subsequent activation of the p38 signaling pathway (Laborde, 2010).